Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Active not recruiting 5Unknown 3Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Prostate Adenocarcinoma 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 316Cyclophosphamide 296pembrolizumab 281Cisplatin 269Carboplatin 246Drug Therapy 238Blood Specimen Collection 233Biopsy 204Bevacizumab 185Gemcitabine 181venetoclax 172Radiosurgery 172Oxaliplatin 164Capecitabine 164fludarabine 161Paclitaxel 158Nivolumab 158Standard of Care 136Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113Rituximab 112tislelizumab 110Cytarabine 104Azacitidine 101Radiation 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Radium-223 × Clear all
NCT06389097 2026-03-30

(SEEtoTREAT)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Recruiting
80 enrolled
Genitourinary

Prostatic Neoplasms

NCT04704505 2026-02-06

BAT-RAD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
47 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡